Kristine Bäck, BSc Pharm

Bio:

Kristine Bäck has 25 years of experience in pharmaceutical development, spanning formulation development, clinical studies, and global development programs across a broad range of therapeutic areas. She has led cross-functional and international development projects from Phase 1 through life cycle management and held senior roles at AstraZeneca, Sobi, Oncopeptides, and Nanexa. Throughout her career, she has been responsible for advancing complex development programs, integrating scientific, clinical, regulatory, and commercial perspectives to support successful product development. Today, she oversees Nanexa's portfolio of internal and partnered development programs, driving the strategic advancement of innovative drug delivery solutions for biologics and other therapeutics.